Skip to main content
. 2019 Dec 26;7(24):4342–4348. doi: 10.12998/wjcc.v7.i24.4342

Table 1.

Clinical features of the reported series of multidrug-resistant Acinetobacter baumannii meningitis in children

Ref. Age (yr) Sex Acinetobacter susceptibility Final regimen(s) Toxicity Treatment outcome
Kaplan et al[10] 4 NR Multidrug resistant Cefotaxime and aminoglycoside IV, and colistin IVR None Cure
Ng et al[11] 4 Male Multidrug resistant Amikacin and colistin IV, and colistin IT Chemical meningitis Cure
Ozdemir et al[12] 3 Female Colistin Colistin and ampicillin–sulbactam IV, and colistin IT None Cure
14 Female Colistin Meropenem and ampicillin–sulbactam IV, and rifampin PO None Cure
1 Male Colistin Colistin and meropenem IV None Cure
Lee et al[13] 3 Male Imipenem Colistin IV None Cure
Ganjeifar et al[14] 6 Male Doxycycline and rifampin Colistin and rifampin IV, and colistin IVR NR Cure
Jiménez-Mejías et al[15] 14 Male Colistin Colistin IV None Cure

IT: Intrathecal; IV: Intravenous; IVR: Intraventricular; PO: Peroral; NR: Not reported.